Published in Genome Biol on July 29, 2013
MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci (2013) 1.19
Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One (2014) 1.07
Bias in microRNA functional enrichment analysis. Bioinformatics (2015) 1.07
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry (2014) 1.03
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease. PLoS One (2015) 1.02
Epigenomics of Alzheimer's disease. Transl Res (2014) 1.01
Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers. Front Mol Neurosci (2013) 1.01
Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One (2015) 0.96
miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med (2014) 0.95
The human miRNA repertoire of different blood compounds. BMC Genomics (2014) 0.95
MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem (2013) 0.93
Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging (Albany NY) (2013) 0.92
Prioritizing and selecting likely novel miRNAs from NGS data. Nucleic Acids Res (2015) 0.91
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status. Genome Biol (2015) 0.90
Chronic academic stress increases a group of microRNAs in peripheral blood. PLoS One (2013) 0.87
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. Biomark Insights (2015) 0.87
Whole exome sequencing in females with autism implicates novel and candidate genes. Int J Mol Sci (2015) 0.87
Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma. BMC Genomics (2014) 0.86
Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases? BMC Res Notes (2014) 0.85
cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs. Clin Epigenetics (2016) 0.85
High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Oncotarget (2016) 0.85
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem (2014) 0.84
Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Int J Mol Sci (2016) 0.84
Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects. Virol J (2014) 0.84
Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity. Toxicol Lett (2014) 0.84
Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle. Cancer Res (2014) 0.83
miRSeq: a user-friendly standalone toolkit for sequencing quality evaluation and miRNA profiling. Biomed Res Int (2014) 0.83
microRNA-Based Biomarkers and the Diagnosis of Alzheimer's Disease. Front Neurol (2015) 0.83
Circulating microRNA-144-5p is associated with depressive disorders. Clin Epigenetics (2015) 0.82
Epigenetic regulation of adult neural stem cells: implications for Alzheimer's disease. Mol Neurodegener (2014) 0.82
Viral miRNAs in plasma and urine divulge JC polyomavirus infection. Virol J (2014) 0.79
miEAA: microRNA enrichment analysis and annotation. Nucleic Acids Res (2016) 0.79
Longitudinal study on circulating miRNAs in patients after lung cancer resection. Oncotarget (2015) 0.79
Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response. Int J Mol Sci (2015) 0.79
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study. Transl Neurodegener (2016) 0.78
Are microRNAs true sensors of ageing and cellular senescence? Ageing Res Rev (2016) 0.78
A study of microRNAs from dried blood spots in newborns after perinatal asphyxia: a simple and feasible biosampling method. Pediatr Res (2015) 0.78
miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease. Alzheimers Res Ther (2016) 0.78
Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease. RNA (2015) 0.78
Genomics in neurological disorders. Genomics Proteomics Bioinformatics (2014) 0.78
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis. J Neuroinflammation (2015) 0.78
NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases. Database (Oxford) (2015) 0.77
Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease. Sci Rep (2016) 0.77
Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease. Front Cell Neurosci (2015) 0.77
miFRame: analysis and visualization of miRNA sequencing data in neurological disorders. J Transl Med (2015) 0.77
CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study. Mol Neurobiol (2016) 0.76
Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs. Genomics Proteomics Bioinformatics (2015) 0.76
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations. Mol Neurobiol (2016) 0.76
MicroRNA Response of Primary Human Macrophages to Arcobacter Butzleri Infection. Eur J Microbiol Immunol (Bp) (2016) 0.76
A serum miRNA profile of human longevity: findings from the Baltimore Longitudinal Study of Aging (BLSA). Aging (Albany NY) (2016) 0.76
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Acta Neuropathol Commun (2017) 0.75
Characterization of miR-206 Promoter and Its Association with Birthweight in Chicken. Int J Mol Sci (2016) 0.75
Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Front Aging Neurosci (2016) 0.75
MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences. Mol Pain (2015) 0.75
miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications. Front Cell Neurosci (2016) 0.75
Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells. Curr Alzheimer Res (2014) 0.75
EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurol (2015) 0.75
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front Neurol (2017) 0.75
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects. Oncotarget (2017) 0.75
MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity. J Exp Neurosci (2016) 0.75
Exploring Biomarkers for Alzheimer's Disease. J Clin Diagn Res (2016) 0.75
Blood miRNomes and transcriptomes reveal novel longevity mechanisms in the long-lived bat, Myotis myotis. BMC Genomics (2016) 0.75
Exploring ncRNAs in Alzheimer's disease by miRMaster. Oncotarget (2016) 0.75
A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease. Front Aging Neurosci (2016) 0.75
Identification of miR-34a-target interactions by a combined network based and experimental approach. Oncotarget (2016) 0.75
MicroRNAs circulate around Alzheimer's disease. Genome Biol (2013) 0.75
The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One (2017) 0.75
MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins. Oncotarget (2017) 0.75
A comprehensive simulation study on classification of RNA-Seq data. PLoS One (2017) 0.75
voomDDA: discovery of diagnostic biomarkers and classification of RNA-seq data. PeerJ (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res (2010) 25.85
Controlling the false discovery rate in behavior genetics research. Behav Brain Res (2001) 21.82
Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health (1998) 9.58
Characterization of microRNA expression profiles in normal human tissues. BMC Genomics (2007) 8.01
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res (2011) 5.83
miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA (2008) 5.48
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
An analysis of human microRNA and disease associations. PLoS One (2008) 5.21
GeneTrail--advanced gene set enrichment analysis. Nucleic Acids Res (2007) 5.10
Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics (2007) 4.91
snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res (2006) 4.80
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol (2007) 3.26
Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol (2012) 3.03
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res (2011) 2.82
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging (2010) 2.32
Understanding microRNAs in neurodegeneration. Nat Rev Neurosci (2009) 2.22
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 2.14
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis (2008) 1.89
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86
Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol (2010) 1.67
Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging (2006) 1.57
Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol (2011) 1.49
TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics (2010) 1.49
MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio (2007) 1.43
Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One (2010) 1.37
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease. J Neurosci (2011) 1.27
Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol (2008) 1.26
MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis (2010) 1.26
MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun (2010) 1.21
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. PLoS One (2011) 1.19
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor. Brain Res (2010) 1.18
MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One (2010) 1.15
Cyclin D2 in the basal process of neural progenitors is linked to non-equivalent cell fates. EMBO J (2012) 1.11
Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol (2012) 1.08
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener (2011) 1.05
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
A case-control association study between the GRID1 gene and schizophrenia in the Chinese Northern Han population. Schizophr Res (2007) 0.99
Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter. Schizophr Res (2009) 0.97
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res (2011) 0.97
Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS One (2012) 0.96
Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet (2012) 0.96
MicroRNAs as active players in the pathogenesis of multiple sclerosis. Int J Mol Sci (2012) 0.96
Neuropeptide Y receptor in the rat brain. Eur J Biochem (1984) 0.92
Perspective: prevention is better than cure. Nature (2011) 0.91
No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology (2012) 0.89
Recent advances in imaging Alzheimer's disease. J Alzheimers Dis (2013) 0.85
Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers. Neurosci Lett (2012) 0.84
New insights on Alzheimer's disease diagnostic. Rom J Morphol Embryol (2011) 0.79
[Biomarkers for early diagnosis of Alzheimer's disease: current update and future directions]. Rev Neurol (Paris) (2008) 0.77
GeneTrail--advanced gene set enrichment analysis. Nucleic Acids Res (2007) 5.10
Recombination: Multiply infected spleen cells in HIV patients. Nature (2002) 4.38
No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol (2010) 4.31
The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89
Transgenic mice with a reduced core body temperature have an increased life span. Science (2006) 3.37
Photoreceptor layer thinning in idiopathic Parkinson's disease. Mov Disord (2014) 3.36
New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing. Nat Commun (2012) 3.18
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol (2005) 2.90
BNDB - the Biochemical Network Database. BMC Bioinformatics (2007) 2.75
High-fidelity gene synthesis by retrieval of sequence-verified DNA identified using high-throughput pyrosequencing. Nat Biotechnol (2010) 2.68
Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet (2011) 2.45
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol (2008) 2.40
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 2.14
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol (2012) 2.12
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med (2009) 2.08
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci (2006) 1.93
Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes (2006) 1.89
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol (2010) 1.87
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
MR-elastography reveals degradation of tissue integrity in multiple sclerosis. Neuroimage (2009) 1.83
Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol (2013) 1.79
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol (2013) 1.78
Cytokines and fever. Front Biosci (2004) 1.78
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 1.77
GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics (2008) 1.77
Neurological aspects of taste disorders. Arch Neurol (2003) 1.74
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol (2011) 1.73
CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol (2005) 1.72
Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol (2013) 1.69
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology (2012) 1.67
Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart J (2013) 1.65
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A (2008) 1.64
A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain (2008) 1.64
Activity-dependent plasticity in an olfactory circuit. Neuron (2007) 1.63
MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc Natl Acad Sci U S A (2006) 1.61
miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer (2009) 1.61
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.58
A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem (2011) 1.58
GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res (2005) 1.57
IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun (2011) 1.57
Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci U S A (2005) 1.56
A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res (2010) 1.54
Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment. Neurology (2009) 1.53
T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology (2013) 1.51
The promise of single-cell sequencing. Nat Methods (2014) 1.51
Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol (2006) 1.48
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci (2010) 1.45
Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2013) 1.42
Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol (2002) 1.42
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer (2005) 1.42
Computation of significance scores of unweighted Gene Set Enrichment Analyses. BMC Bioinformatics (2007) 1.41
Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS One (2012) 1.41
Diverse odor-conditioned memories require uniquely timed dorsal paired medial neuron output. Neuron (2004) 1.41
Neuropeptides: opportunities for drug discovery. Lancet Neurol (2003) 1.41
Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma (2002) 1.40
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A (2007) 1.40
Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer (2011) 1.38
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
Perivascular spaces--MRI marker of inflammatory activity in the brain? Brain (2008) 1.33
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol (2009) 1.32
High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer (2010) 1.32
Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg (2010) 1.30
Deciphering the porcine intestinal microRNA transcriptome. BMC Genomics (2010) 1.30
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler (2013) 1.30
Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci U S A (2002) 1.29
Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics (2008) 1.29